What is SciMetrika?
SciMetrika operates as a specialized provider of data-driven solutions designed to improve public health outcomes and bolster emergency response frameworks. The company offers a comprehensive suite of services, including rigorous data collection, technical assistance, and the implementation of sustainable health programs. Their expertise in radiation emergency preparedness and risk assessment makes them a vital partner for federal agencies, state health departments, and various consumer services organizations. By focusing on population health, SciMetrika enables its clients to execute targeted interventions that protect communities and promote health equity across diverse demographics.
How much funding has SciMetrika raised?
SciMetrika has raised a total of $40M across 1 funding round:
Unspecified
$40M
Unspecified (2013): $40M with participation from U.S. Food and Drug Administration
Key Investors in SciMetrika
U.S. Food and Drug Administration
The U.S. Food and Drug Administration is a federal public health agency responsible for protecting and promoting public health by regulating a broad range of products, including medicines, medical devices, and radiation-emitting commodities.
What's next for SciMetrika?
With the recent influx of capital, SciMetrika is strategically positioned to scale its enterprise-level operations and deepen its engagement with federal health infrastructure. The company is expected to prioritize the development of more sophisticated analytical tools that can address emerging public health threats and climate-related health risks. Furthermore, the firm will likely focus on expanding its technical assistance portfolio, ensuring that local and state health departments have the necessary resources to implement long-term, sustainable health equity initiatives. This growth trajectory suggests a continued commitment to bridging the gap between complex data analysis and actionable, real-world health policy.
See full SciMetrika company page
